IL17A and psoriasis: Studies have shown that CXCL16 has chemotactic effects on CD4+ T cells, and further activates CD8+ T cells, thereby promoting the secretion of IFN-γ, IL-17 and TNF-α, etc., and is involved in the pathogenesis of psoriasis progress (18).